Abbott says market overestimating sales hit from new diabetes drugs
Go back to Abbott says market overestimating sales hit from new diabetes drugs| Abbott Laboratories (NYSE: ABT) | Delayed: 102.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.23 | 52 Week High | $46.38 | |||
| Open | $102.15 | 52 Week Low | $36.00 | |||
| Day High | $103.00 | P/E | 68.15 | |||
| Day Low | $100.33 | EPS | $1.50 | |||
| Volume | 3,617 | |||||
